Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Liquidia Corporation - Common Stock (NQ: LQDA )

12.29 +0.19 (+1.57%)
Streaming Delayed Price Updated: 4:00 PM EST, Jan 3, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 645,717
Open 12.08
Bid (Size) 12.20 (2)
Ask (Size) 12.25 (1)
Prev. Close 12.10
Today's Range 11.97 - 12.51
52wk Range 8.260 - 16.99
Shares Outstanding 76,793,694
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
The Analyst Landscape: 11 Takes On Liquidia
Via Benzinga

Performance

YTD
+1.57%
+1.57%
1 Month
+7.06%
+7.06%
3 Month
+10.22%
+10.22%
6 Month
-1.21%
-1.21%
1 Year
-2.92%
-2.92%

More News

Read More
Liquidia Corporation Reports Third Quarter 2024 Financial Results and Provides Corporate Update
From Liquidia Corporation
Via GlobeNewswire
Earnings Scheduled For November 13, 2024
Via Benzinga
Uncovering Potential: Liquidia's Earnings Preview
Via Benzinga
Liquidia to Present at the Stifel 2024 Healthcare Conference
From Liquidia Corporation
Via GlobeNewswire
Evaluating Liquidia: Insights From 14 Financial Analysts
Via Benzinga
Liquidia Corporation to Report Third Quarter 2024 Financial Results on November 13, 2024
From Liquidia Corporation
Via GlobeNewswire
Liquidia Corporation to Report Third Quarter 2024 Financial Results on November 11, 2024
From Liquidia Corporation
Via GlobeNewswire
Pfizer, Vista Outdoor, Duckhorn Portfolio And Other Big Stocks Moving Higher On Monday
Via Benzinga
United States Supreme Court Declines to Review Rulings that Invalidate United Therapeutics’ Patent
From Liquidia Corporation
Via GlobeNewswire
Liquidia and Pharmosa Biopharm Expand Collaboration to Develop Sustained Release Inhaled Treprostinil (L606)
From Liquidia Corporation
Via GlobeNewswire
Bragar Eagel & Squire, P.C. Is Investigating Liquidia, Napco, and Franklin and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
Liquidia Announces Poster Presentation and Medical Theater at the CHEST 2024 Annual Meeting
From Liquidia Corporation
Via GlobeNewswire
Bragar Eagel & Squire, P.C. Is Investigating Paragon 28, Centuri, Liquidia, and Elastic and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
Court Finds United Therapeutics’ Interference with Launch of Generic Treprostinil Injection Caused Losses of More Than $137 Million
From Liquidia Corporation
Via GlobeNewswire
Nasdaq Surges Over 200 Points; US Crude Oil Stocks Increase
Via Benzinga
Exposures Fossil Fuels
Petco, AppLovin, Dave & Buster's And Other Big Stocks Moving Higher On Wednesday
Via Benzinga
Liquidia Corporation Announces Raise of $67.5 Million from New Common Stock Financings and $32.5 Million Advance from HealthCare Royalty Under Current Financing Agreement
From Liquidia Corporation
Via GlobeNewswire
Bronstein, Gewirtz and Grossman, LLC Announces an Investigation Against Liquidia Technologies, Inc. (LQDA) and Encourages Shareholders to Seek Compensation for Alleged Wrongdoings
From Bronstein, Gewirtz & Grossman, LLC
Via Business Wire
Bronstein, Gewirtz and Grossman, LLC Announces an Investigation Against Liquidia Technologies, Inc. (LQDA) and Encourages Shareholders to Seek Compensation for Alleged Wrongdoings
From Bronstein, Gewirtz & Grossman, LLC
Via Business Wire
Liquidia to Present at Upcoming Investor Conferences
From Liquidia Corporation
Via GlobeNewswire
LIQUIDIA ALERT: Bragar Eagel & Squire, P.C. is Investigating Liquidia Corporation on Behalf of Liquidia Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
Kirby McInerney LLP Announces Investigation of Shareholder Claims Against Liquidia Corporation (LQDA)
From Kirby McInerney LLP
Via Business Wire
Liquidia Files Litigation to Challenge Regulatory Exclusivity Blocking Access to YUTREPIA™ (treprostinil) inhalation powder for Patients Suffering with PAH and PH-ILD
From Liquidia Corporation
Via GlobeNewswire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.